GlassScriptPhysician profile
Emma Dambi
NPI 1497250195
$6,780.69
in general payments reported to CMS, 2019-2025
13 companies · $724 in 2025
The $724 reported for 2025 was more than what 81% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,850 · 2022: $1,073 · 2023: $1,422 · 2024: $712 · 2025: $724.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,857.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,857.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,915.29 | 2021-2025 | Proclaim, Eterna, Octrode |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $330.71 | 2022-2024 | Relistor |
| Boston Scientific Corporation | $197.26 | 2023-2025 | Intracept, Superion Indirect Decompression System |
| Radius Health, INC. | $60.07 | 2021-2022 | |
| Biodelivery Sciences International, INC. | $58.52 | 2021 | |
| Saluda Medical Americas, INC. | $52.34 | 2024 | Evoke |
| Nevro Corp. | $33.72 | 2021-2022 | |
| Fidia Pharma USA INC. | $27.93 | 2024 | Hymovis |
| Spr Therapeutics, INC | $27.19 | 2022 | |
| Almatica Pharma LLC | $24.16 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $19.99 | 2025 | |
| Medtronic, INC. | $19.70 | 2022 | |
| Nalu Medical, INC. | $13.81 | 2023 | Nalu Neurostimulation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emma Dambi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.